|
|
Volumn 295, Issue 5560, 2002, Pages 1616-1617
|
|
Biomedical research: Disappointing data scuttle plans for large-scale AIDS vaccine trial
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
NAKED DNA;
HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;
RECOMBINANT VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BUDGET;
CLINICAL RESEARCH;
DRUG COST;
DRUG EFFICACY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NOTE;
PRIORITY JOURNAL;
UNITED STATES;
VACCINE PRODUCTION;
ARTICLE;
BIOSYNTHESIS;
CLINICAL TRIAL;
CYTOTOXICITY;
FINANCIAL MANAGEMENT;
HEALTH CARE ORGANIZATION;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNOLOGY;
KILLER CELL;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AIDS VACCINES;
CLINICAL TRIALS;
CYTOTOXICITY, IMMUNOLOGIC;
FINANCING, GOVERNMENT;
HIV;
HIV ANTIBODIES;
HUMANS;
KILLER CELLS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
RESEARCH SUPPORT;
UNITED STATES;
VACCINES, DNA;
VACCINES, SYNTHETIC;
|
|
EID: 0036500595
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.295.5560.1616 Document Type: Note |
|
Times cited : (20)
|
|
References (0)
|